TrialAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2025

Mineralocorticoid Receptor Antagonism with Finerenone: A New Era in the Management of Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction.

Panagiotis I Georgianos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.